PRESS RELEASE: The Pharmaceutical Compliance Forum's Third International Pharmaceutical Regulatory Compliance Congress Announces that its Conference Content Is Now Available Online and via DVD, Thumb Drive and iPod nano
PRESS RELEASE
Phone: 800-684-4549
Email: registration@hcconferences.com
Website: www.InternationalPharmaCongress.com

WASHINGTON DC USA -- PHARMA UPDATE NEWS SERVICE™ -- JULY 21, 2009: The International Pharmaceutical Regulatory and Compliance Congress, www.InternationalPharmaCongress.com, held May 28 - 29, 2009, announces the release of its content in various post conference formats.

INTERNATIONAL PHARMA CONGRESS CONTENT IS NOW AVAILABLE IN VARIOUS POST CONFERENCE FORMATS

The International Pharma Congress conference content is now available in a variety of formats.

YOU CAN PURCHASE JUST THE INTERNATIONAL PHARMA CONGRESS CONTENT AS FOLLOWS:

iPod nano of 2009 International Pharma Congress Presentations
$395
Order Now

Data DVD of 2009 International Pharma Congress Presentations
$245
Order Now

Flash Drive of 2009 International Pharma Congress Presentations
$245
Order Now

Online Archive of 2009 International Pharma Congress Presentations
Complete conference: $395
Order Now

FINALLY YOU MAY PURCHASE INTERNATIONAL PHARMA CONGRESS INDIVIDUAL PRESENTATIONS:
Click here to purchase individual presentations for $19.95 in online archive format (6 months of access - 24/7).



CONGRESS THEME: GETTING TO A HIGH INTEGRITY FUTURE SUSTAINABLY

FEATURING THE FOLLOWING PRECONFERENCE SESSIONS
  • International Compliance Program Basics
  • FCPA, Antibribery and Anticorruption
  • Compliance Risk Management

SPECIAL SESSIONS ON
  • Compliance in a Tough Economy
  • The New EU Regulatory Pharmaceutical Package
  • The WHO Approach to Supporting Anticorruption
  • Increasing Regulatory Scrutiny
  • Consolidation and Harmonization of Codes
  • Managing Cultural Differences in a Consolidation and Harmonization Environment
  • Fighting Corruption
  • Fighting Counterfeits and Diversion: EU Pharma Package, US and WHO Proposals
  • Transparency
  • the Issues and Pitfalls of Sponsoring International Events
  • Information for Patients Under the New Pharma Package
  • Addressing the Challenges of Industry's Reputation in a Transparent and Sustainable Fashion
  • Investigations
  • Clinical Trials in Emerging Markets
  • Lesson Learned for the Siemens' Case
  • Life after Compliance: Why Compliance is Critical to a Business Leader
  • Compliance Coordination with the Device Sector
  • International Compliance Professional Roundtable
  • Practical Side of Getting the Basics Right

CONGRESS CO CHAIRS

Sue Egan
Vice President Compliance, AstraZeneca PLC, London, UK

Lori Queisser
Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation, Kenilworth, NJ, USA

Roeland van Aelst
Executive Director International, WW Office Health Care Compliance & Privacy (EMEA, Canada, Lat-Am, Asia-Pac), Johnson & Johnson


FEATURED FACULTY

Guitelle Baghdadi-Sabeti, MD
Technical Officer, Medicines, Policies and Standards Department, World Health Organization, Geneva, Switzerland

Richard Bergstrom, MscPharm
Managing Director, Swedish Association of the Pharmaceutical Industry, Chairman, IFPMA Code Compliance Network, Chairman, EFPIA Code Steering Committee, Stockholm, Sweden

Nicola Braggio
Marketing Company President, Astrazeneca Italy, Milan, Italy

Wolf-Dietrich Guhl, Esq.
Chief Compliance Officer, Healthcare Sector, Siemens AG, Munich, Germany


Marie-Claire Pickaert
Deputy Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium

Heather Simmonds
Director, Prescription Medicines Code of Practice Authority, London, UK

John Wilkinson
Chief Executive, Eucomed, Former Director General, Association of British Healthcare Industries Ltd., Brussels, Belgium

Jose Zamarriego
Director, Code of Practice Surveillance Unit, Farmaindustria, Madrid, Spain


LEADING COMPLIANCE PROFESSIONALS AND LEGAL COUNSEL

Thomas E. Costa
Vice President, U.S. Pharmaceuticals Compliance & Ethics, Bristol-Myers Squib, Princeton, NJ USA

Gabor Danielfy
Senior Director, Health Care Compliance and Privacy EMEA, Johnson & Johnson, Issy-les-Moulineaux, France



Pierre E. Dupourque
Regional Compliance Director, Corporate Compliance, International Investigations and Programs, Pfizer, Inc., Mannheim, Germany

Michael Dusseau
Executive Director, Compliance Services, Global Compliance and Business Practices, Schering-Plough Corporation, Kenilworth, NJ USA

Michael Fadus
Regional Compliance Director, Central & Eastern Europe, Schering-Plough Corporation, Lucerne, Switzerland



Sameh Farag
Regional Compliance Director, MEA, Schering-Plough Corporation, Dubai

Gary F. Giampetruzzi, Esq.
Deputy Compliance Officer, International, Investigations and Programs, Pfizer Inc., New York, NY USA

Dominique Laymand, Esq.
Senior Director Compliance & Ethics EMEA (Europe, Middle East, Turkey, Russia and Africa), Bristol-Myers Squibb, Paris, France

Steve Mohr, Esq.
Global Compliance Officer, AstraZeneca, London, UK

David O'Shaughnessy
Vice President and Compliance Officer, Emerging Markets & Asia Pacific, GlaxoSmithKline, Brentford, Middlesex, UK

Michael Shaw
Global Head, Ethics & Compliance, Novartis Oncology, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, Florham Park, NJ USA

Willy Vanbuggenhout, JD, MBA
Chief Compliance Officer, Johnson & Johnson, Brussels, Belgium

Paul B. Woods, BPharm, MA, MRPharmS
Global Compliance Policy Director, AstraZeneca, Macclesfield, Cheshire, UK


PROMINENT COMPLIANCE CONSULTANTS AND LEGAL ADVISORS

Ted Acosta, Esq.
Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France

Mark Barnes, Esq.
Managing Director, Huron Consulting Group, New York, NY, USA

John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP, Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, Department of Justice, Washington, DC, USA

Jennifer Colapietro
Director, Pharmaceutical and Life Sciences Advisory Services, PricewaterhouseCoopers LLC, Florham Park, NJ USA

Tim Frazer, Esq.
Partner, Arnold & Porter (UK) LLP, Former Professor and Dean of Law, Newcastle University, London, UK

Paul V. Gerlach, Esq.
Partner, Sidley Austin LLP, Former Associate Director, Division of Enforcement, US Securities & Exchange Commission, Washington, DC

Linda R. Horton, Esq.
Partner, Hogan & Hartson LLP, Washington, DC, USA and Brussels, Belgium

Jonathon L. Kellerman
Partner, Pharmaceutical and Life Sciences Practice, PricewaterhouseCoopers LLP, Philadelphia, PA USA

Maurits J.F. Lugard, MA, JD, LLM
Partner, Sidley Austin LLP, Former Member of the European Commission's Legal Service, Brussels, Belgium

SanDee Priser
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Germany

Allison Weber Shuren, MSN, JD
Arnold & Porter LLP, Washington, DC

Yuet-Ming Tham, Esq.
Senior Regulatory Consultant , DLA Piper, Former Regional Compliance Director, Legal Division, Corporate Compliance, Pfizer Inc., Hong Kong

Elisabethann Wright, Esq.
Partner, Hogan & Hartson, Former Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium


CONGRESS CONTENT PURCHASING INFORMATION

Choose from the following purchase options:




BROCHURE AVAILABLE
Click here to view the brochure.
SPONSORED BY:


The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs. The members meet twice a year, for two days, focusing on open and informal sharing of compliance information, best practices, and current developments in the field, and sponsors a two-day international compliance congress in the Spring and a three-day US compliance congress each Fall.

GRANTORS:
DIAMOND




BRONZE










ADDITIONAL


PUBLICATION SPONSORS











































SAVE THE DATES


FOURTH ANNUAL MEDICAL DEVICE REGULATORY, REIMBURSEMENT AND COMPLIANCE CONGRESS
November 9 - 11, 2009
JW Marriott Hotel
Washington, DC
www.DeviceCongress.com

TENTH ANNUAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
Sponsored by Pharmaceutical Compliance Forum
November 11 - 13, 2009
JW Marriott Hotel
Washington, DC
www.PharmaCongress.com





We subscribe to the HONcode principles of the HON Foundation. Click to verify.





2009 INTERNATIONAL PHARMA CONGRESS PLANNING COMMITTEE
Click here for the International Pharma Congress Planning Committee.